Clinical Report: Cancer Therapy in Pregnancy and Maternal–Infant Outcomes

Overview

This descriptive cohort study used Japanese claims data and mother–infant linkage to characterize cancer treatment and outcomes among 500 pregnancies with cancer diagnosed before delivery. The supplied article text describes the study design and cohort but does not provide treatment or outcome results, so findings about those outcomes cannot be summarized from the available material.

Background

Cancer management during pregnancy requires consideration of maternal treatment and potential fetal effects, as well as coordination with delivery. Pregnant patients are generally excluded from oncology trials, leaving much of the evidence base in case reports, single-center series, and expert consensus. The article notes that guidelines support standard oncological treatment when regimens are considered acceptable after the first trimester, while population-level implementation remains uncertain. This study used linked maternal and infant claims to describe treatment and outcomes in Japan, with pregnancies lacking a malignant neoplasm diagnosis serving as a background benchmark rather than a causal comparator.

Data Highlights

Key Findings

• The study was a descriptive cohort analysis of a mother–infant-linked extract from Japan’s JMDC employment-based health insurance claims database.
• Eligible pregnancies required an estimated gestational age of 22–42 weeks, maternal follow-up from 3 months before pregnancy onset through delivery, and infant observation for at least 6 months after birth or death during that interval.
• Pregnancy-associated cancer was defined as a malignant neoplasm diagnosed from estimated pregnancy onset through 1 year postpartum; 500 pregnancies with cancer diagnosed before delivery formed the analytical cohort.
• The 568 pregnancies with cancer diagnosed postpartum were excluded from further analysis, and 15 pregnancies were removed because the qualifying diagnosis pertained to a different pregnancy in the same woman.
• The internal reference group comprised 236,002 pregnancies without malignant neoplasm diagnoses and was specified as a background benchmark, not a comparator for causal inference.
• The supplied article excerpt ends at the exposure-definition section and contains no reported treatment patterns or maternal and infant outcome estimates.

Clinical Implications

The available material establishes the cohort definitions and claims-based approach but does not report the treatment or outcome results needed to draw clinical conclusions. The study’s internal reference group should be interpreted as a descriptive benchmark, not as evidence of causal effects.

Conclusion

The article describes a large Japanese claims-based cohort designed to examine cancer treatment during pregnancy and linked maternal and infant outcomes. Because the supplied text does not include the results, no outcome-specific conclusions can be stated.

Related Resources & Content

1. Study authors not provided, Source not provided, Year not provided — Cancer Therapy in Pregnancy and Outcomes for Mothers and Infants: A Descriptive Cohort Study Based on Japanese Claims Data
2. Society for Maternal-Fetal Medicine, SMFM Consult Series #76, 2026 — Cancer in pregnancy
3. American Society of Clinical Oncology, Journal of Clinical Oncology, 2025 — Management of Cancer During Pregnancy: ASCO Guideline
4. ASCO Publications — Pregnancy and cancer: A retrospective case series of obstetric, oncologic, and care-compliance outcomes.
5. ASCO Publications — Pregnancy and cancer: A retrospective case series of obstetric, oncologic, and care-compliance outcomes.
6. ASCO Publications — Pregnancy and cancer: A retrospective case series of obstetric, oncologic, and care-compliance outcomes.
7. ASCO Publications — Assessment of the treatment results in patients with breast cancer coexisting with pregnancy: A single-center observational study.
8. Society for Maternal-Fetal Medicine Consult Series #76: Cancer in pregnancy
9. Management of Cancer During Pregnancy: ASCO Guideline
10. Management of Cancer During Pregnancy: ASCO Guideline | Journal of Clinical Oncology
11. Brazil - Gestational outcomes in cancer patients during pregnancy: systematic review and meta-analysis Gestational outcomes in cancer patients during pregnancy: systematic review and meta-analysis